Rate My Professor Philip Pattemore

Pattemore's research specializations encompass the epidemiology and natural history of asthma and bronchial hyperresponsiveness, viral infections as triggers of asthma exacerbations, asthma management strategies, risks to children from environmental tobacco smoke exposure, and cystic fibrosis lung disease with emphasis on infection and oxidative damage. He has contributed significantly to international paediatric respiratory research, notably through participation in the International Study of Asthma and Allergies in Childhood (ISAAC), resulting in highly cited publications such as 'Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC' (1998, European Respiratory Journal) and 'Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC)' (1998, European Respiratory Journal). Recent works include 'Cough and cough hypersensitivity as treatable traits of asthma' (2023, The Lancet Respiratory Medicine), 'Sputum inflammatory, neural, and remodeling mediators in eosinophilic and noneosinophilic asthma' (2023, Annals of Allergy, Asthma & Immunology), and studies on vaping risks and knowledge among New Zealand high school students (2023, 2025, New Zealand Medical Journal). His scholarly output totals over 100 publications with more than 9,300 citations.